Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a
global population of more than 35 million people living with HIV, there is intense interest in …

There is pressing urgency to understand the pathogenesis of the severe acute respiratory
syndrome coronavirus clade 2 (SARS-CoV-2), which causes the disease COVID-19. SARS-…

Although combination antiretroviral therapy can dramatically reduce the circulating viral load
in those infected with HIV, replication-competent virus persists. To eliminate the need for …

… e–h, Frequency of arrhythmias is highest within the first 2 weeks after hESC-CM … or AIVR
for more than 18 h per 24 h period). NSAIVR, non-sustained accelerated idioventricular rhythm. …

Toxicities have limited the use of allogeneic hematopoietic cell transplantation (HCT) to
younger, medically fit patients. In a canine HCT model, a combination of postgrafting …

… at -20C for at least 20 h. Sections were stained either with … intravenously into SCID mice
3-48 h after irradiation. 10 U/ml … into two equal doses and injected 24 h apart. Animals were …

Postgrafting cyclosporine (CSP) given for 35 days resulted in establishment of stable marrow
grafts from DLA-identical canine littermates after otherwise suboptimal, but nevertheless, …

Risk factors for grades 2-4 acute graft-versus-host disease (GVHD) and for chronic GVHD as
defined by National Institutes of Health consensus criteria were evaluated and compared in …

Despite promising results in preclinical studies, only a handful of clinical trials have been
initiated worldwide. Several obstacles remain prior to successful application of HIV-specific …

The small number of hematopoietic stem and progenitor cells in cord blood units limits their
widespread use in human transplant protocols. We identified a family of chemically related …